195rar -

SYK must physically touch FLT3 to activate it.

Because this specific interaction is so vital for the cancer to progress, it identified a new potential "weak spot" that future drugs could target to treat AML more effectively. 195rar

To prove that SYK was directly talking to FLT3, scientists needed to break the physical connection between them. They focused on a specific part of the SYK protein called the . SYK must physically touch FLT3 to activate it

In a study published in , scientists investigated a protein called SYK (Spleen Tyrosine Kinase). They knew SYK was present in blood cancers but weren't sure exactly how it contributed to the disease. They discovered that SYK acts as a "partner in crime" with another protein called FLT3 , which is frequently mutated in leukemia patients. The 195RAR Mutation They focused on a specific part of the

In scientific research, "195RAR" refers to a specific genetic mutation used to study how certain proteins interact within the body, particularly in the context of cancer development.

The story of is a technical one, centered on the SYK protein and its role in Acute Myeloid Leukemia (AML) . Researchers used this mutation to unlock a secret about how cancer cells survive and resist treatment. The Mystery of the SYK Protein